Anuh Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma Limited's Promoter and Promoter Group has submitted their yearly disclosure confirming holding of 7,19,56,044 equity shares as of 31st March, 2026. The disclosure lists 37 entities in the promoter group, including individuals and entities like BIPIN NEMCHAND SHAH (HUF) with 84,94,200 shares being the largest holder, followed by PRAFULLA LALIT SHAH with 1,44,99,132 shares. Bharat Nemchand Shah, a Promoter Director, signed the disclosure on behalf of all promoters. Critically, the promoters have explicitly confirmed that they have NOT made any encumbrance (pledge) of these shares, either directly or indirectly, during the financial year ended 31st March, 2026.
The disclosure provides clarity that promoter shares are free of any pledge or encumbrance, which is a positive signal for shareholders as the shares are not locked up as collateral. This transparency helps maintain investor confidence in the stock.